@article{APS7343,
author = {Jun-Ping Zhang and Min Zhang and Jian-Ping Zhou and Fu-Tang Liu and Bin Zhou and Wei-Fen Xie and Cheng Guo and Chun Zhang and Ding-Hua Qian},
title = {Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats},
journal = {Acta Pharmacologica Sinica},
volume = {22},
number = {2},
year = {2016},
keywords = {},
abstract = {Aim: To study the antifibrotic effects of matrine in vitro a nd in vivo.
Methods: Rat hepatic stellate cell HSC-T6 and mouse fibroblast cell NIH3T3 proliferation stimulated with serum and platelet-derived growth factor (PDGF) was measured b y crystal violet staining assay. Collagen synthesis stimulated with serum and transforming growth factor beta1 (TGF-beta1) was determined by [3H]proline incorporation. Liver fibrosis was induced by carbon tetrachloride (CCl4) in rats an d evaluated with plasma hyaluranic acid level and hepatic hydroxyproline content.
Results: Matrine (1-2 mmol/L) markedly reduced serum-driven proliferation and collagen synthesis of HSC-T6 cells as well as NIH3T3 cells. PDGF-driven proliferative activity and TGF-beta1-driven collagen synthesis in HSC-T6 cel ls were attenuated by matrine (0.25-2 mmol/L) in a concentration-dependent manner. In vivo matrine (50 mg/kg and 100 mg/kg) significantly decreased serum hyaluranic acid levels and hepatic hydroxyproline contents in rats treated with CCl4.
Conclusion: Inhibition of PDGF and TGF-beta1 actions on hepatic stellate cell by matrine might provide a possible mechanism of its antifibrotic activities.},
issn = {1745-7254}, url = {http://www.chinaphar.com/article/view/7343}
}